Bailard’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bailard’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-5,111	Closed	-$1.01M	–	256
2013 Q4	$1.01M	Hold	5,111	–	–	0.16%	83
2013 Q3	$864K	Sell	5,111 -256	-5%	-$41.2K	0.16%	110
2013 Q2	$952K	Buy	+5,367	New	+$760K	0.17%	107

Other funds holding LUMO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TAM

Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Bailard's LUMO Position: Q1 2014 in Review

Bailard sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2014, closing a stake of 5,111 shares — an estimated $1.01M sold.

Bailard first reported a position in LUMO in Q2 2013 and held it in 3 quarters. The position peaked at $1.01M in Q4 2013. 94 funds tracked by Wall St. Rank hold LUMO as of Q1 2014.

Bailard reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
Bailard sold 5,111 Lumos Pharma, Inc. Common Stock shares in Q1 2014, an estimated $1.01M.
Bailard first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 3 quarters.
Bailard's Lumos Pharma, Inc. Common Stock position peaked at $1.01M in Q4 2013.
94 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2014.

Based on Bailard's 13F filing for Q1 2014, filed 30 Apr 2014.